Skip to main content
. 2021 Jun 21;10(12):2734. doi: 10.3390/jcm10122734

Figure 2.

Figure 2

(A) Percentage of smokers in the control group and the eosinophil-guided group receiving systemic corticosteroids from days 1–5. (B) Percentage of ex-smokers in the control group and the eosinophil-guided group receiving systemic corticosteroids from days 1–5.